Gmt Capital Corp Takeda Pharmaceutical CO LTD Transaction History

Gmt Capital Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$13.54 - $15.35 $8.25 Million - $9.35 Million	-609,195 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$13.17 - $16.4 $550,506 - $685,519	-41,800 Reduced 6.42%	609,195 $8.3 Million
Q3 2021 Nov 09, 2021	SELL	$16.3 - $17.26 $9.19 Million - $9.73 Million	-563,700 Reduced 46.41%	650,995 $10.7 Million
Q2 2021 Aug 13, 2021	SELL	$16.55 - $18.64 $20.8 Million - $23.4 Million	-1,254,000 Reduced 50.8%	1,214,695 $20.4 Million
Q1 2021 May 13, 2021	SELL	$16.71 - $19.9 $6.73 Million - $8.01 Million	-402,700 Reduced 14.02%	2,468,695 $45.1 Million
Q4 2020 Feb 09, 2021	BUY	$15.39 - $18.97 $3.66 Million - $4.52 Million	238,100 Added 9.04%	2,871,395 $52.3 Million
Q3 2020 Nov 13, 2020	SELL	$17.1 - $19.19 $12.5 Million - $14 Million	-728,581 Reduced 21.67%	2,633,295 $47 Million
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $3.05 Million - $4.08 Million	-209,200 Reduced 5.86%	3,361,876 $60.3 Million
Q1 2020 May 13, 2020	BUY	$13.02 - $20.31 $2.93 Million - $4.57 Million	225,100 Added 6.73%	3,571,076 $54.2 Million
Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $3.27 Million - $4.03 Million	193,506 Added 6.14%	3,345,976 $66 Million
Q3 2019 Nov 13, 2019	BUY	$16.15 - $17.99 $19 Million - $21.2 Million	1,177,110 Added 59.59%	3,152,470 $54.2 Million
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $6.59 Million - $8.14 Million	397,400 Added 25.18%	1,975,360 $35 Million
Q1 2019 May 13, 2019	BUY	$16.7 - $21.52 $26.4 Million - $34 Million	1,577,960 New	1,577,960 $32.1 Million

338

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Gmt Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Gmt Capital Corp with notifications on news.